Fibrosarcoma due to the Feline Sarcoma Virus, FeSV, injection site-associated fibrosarcoma (tumor, fibrosarcoma after vaccinations and injections) in cats
- Occurrence: very rare
- Location of illness: General/Whole body
Fibrosarcoma in cats, often associated with the Feline Sarcoma Virus (FeSV) or injection sites, is a malignant tumor that develops from connective tissue cells. It often occurs at sites where vaccinations or other injections have been administered.
The most important facts at a glance
Fibrosarcomas in cats are malignant connective tissue tumors that are associated with the Feline Sarcoma Virus (FeSV) in some cases. These retroviruses can integrate genetic material into host cells and promote uncontrolled cell growth. Another risk is the development of fibrosarcomas at injection sites, often caused by the reaction to vaccines or injections that can cause chronic inflammatory conditions. Genetic predispositions can increase the susceptibility of some cats to these tumors. Adjuvants in vaccines may also promote tumor growth through increased inflammatory responses.
Symptoms include palpable nodules in the connective tissue and occasional skin lesions. The diagnosis is made through clinical examinations, fine-needle aspiration or biopsy, supplemented by imaging procedures such as X-ray or MRI. The treatment is complex and often involves surgical removal of the tumor, supplemented by radiation therapy or, rarely, chemotherapy. The prognosis varies depending on tumor size, location, and metastases.
For prevention, injections should be given at well-vascularized sites to allow for easier surgical treatment. Minimizing the number of injections and using adjuvant-free or less reactive vaccines can also reduce the risk. Regular examinations of the injection sites by the owner are important to detect changes early. An open dialogue with the veterinarian about the latest vaccine developments can help optimize the cat’s health.
Causes
Fibrosarcomas are malignant tumors of connective tissue that pose a significant health threat to cats. They are of particular concern because, in some cases, they are related to the feline sarcoma virus (FeSV). These viruses belong to the retrovirus family and are known to integrate genetic material into the genome of host cells, which can lead to uncontrolled cell growth.
Another significant factor is the development of fibrosarcomas at injection sites. These tumors are often referred to as vaccine-associated or injection site-associated fibrosarcomas. Research has shown that the tissue’s response to certain vaccines or injections can lead to chronic inflammatory conditions that may promote tumor growth.
The exact mechanisms that lead to tumor formation can vary. It is believed that some cats have a genetic predisposition that makes them more susceptible to developing fibrosarcomas. Chronic inflammation of the skin or subcutaneous tissue can lead to cell changes that eventually result in a malignant transformation.
The use of adjuvants in vaccines is also discussed as another cause. Adjuvants are substances that are intended to enhance the immune response to a vaccine but can also lead to an increased inflammatory response. Not all cats develop fibrosarcomas after injections, suggesting that individual genetic factors play a role.
Symptoms
The symptoms of fibrosarcomas in cats are often subtle and can easily be overlooked. Often, owners first notice a firm, non-painful Swelling under the skin, often at a site where an injection has recently been administered. This Swelling can grow slowly and is often the first indication of a possible problem.
As the tumor progresses, more noticeable symptoms may occur. The cat may show signs of discomfort, such as loss of appetite, weight loss, or lethargy. In some cases, the tumor may ulcerate, meaning the skin over the tumor may break open and bleed or secrete fluid.
Because fibrosarcomas can aggressively spread into the surrounding tissue, mobility may be impaired, especially if the tumor is located near joints or muscles. In advanced cases, systemic symptoms may occur if the tumor metastasizes, i.e., forms secondary tumors in other parts of the body.
Diagnosis
The diagnosis of fibrosarcoma in cats usually begins with a thorough clinical examination by a veterinarian. A detailed medical history, including information about previous vaccinations or injections and the duration of tumor growth, is crucial.
To determine the nature of the tumor, a fine-needle aspiration or biopsy is often performed. In fine-needle aspiration, a thin needle is used to collect cells from the tumor, which are then examined microscopically. A biopsy provides more comprehensive information because a larger piece of tissue sample is taken for histopathological examination.
Imaging procedures such as X-ray, ultrasound, or magnetic resonance imaging (MRI) can also be used to assess the spread of the tumor and determine whether metastases are present. These examinations also help in planning a possible surgical removal of the tumor.
Therapy
The treatment of fibrosarcomas in cats is complex and often requires a multimodal approach. Surgical removal is the preferred therapy option, with the goal of completely removing the tumor with a wide safety margin to minimize the risk of recurrence / relapse. However, due to the aggressive nature of the tumor, it is often difficult to remove it completely.
In addition to surgery, radiation therapy may be considered to destroy any remaining cancer cells and reduce the likelihood of recurrence / relapse. Chemotherapy is used less often but may be considered in certain cases, especially if metastases are present or the tumor cannot be surgically removed.
After treatment, regular monitoring is crucial to detect any recurrence / relapse of the tumor early. This may include regular visits to the veterinarian and imaging procedures for monitoring.
Prognosis and follow-up care
The prognosis for cats with fibrosarcomas varies considerably and depends on several factors, including the size and location of the tumor, the presence of metastases, and the completeness of surgical removal. With complete removal and no metastases, the prognosis can be favorable, although recurrence / relapse cannot be ruled out.
In cases where the tumor cannot be completely removed or metastases are already present, the prognosis is worse. Aggressive treatment strategies can prolong the cat’s life, but quality of life remains a crucial factor in the treatment decision.
Regular follow-up care and early detection of recurrence / relapse are crucial to ensuring the best possible prognosis.
Prevention
To minimize the risk of fibrosarcoma in cats, careful consideration of the choice of injection sites is crucial. It is recommended to administer vaccinations and other injections at well-vascularized sites that are easier to treat surgically in the event of tumor development, such as on the lateral abdominal wall or on the thigh, rather than in the neck area.
Another important prevention approach is to minimize the number of injections and only perform necessary vaccinations. Discuss with your veterinarian which vaccinations are truly necessary and whether alternative vaccination schedules can be considered. In addition, adjuvant-free vaccines, which cause fewer inflammatory reactions, can reduce the risk.
Regular examinations of the injection sites by the owner are also important. Watch for swelling or nodules at the injection sites and consult a veterinarian if you notice anything unusual. Early detection of changes can significantly improve the prognosis.
In some cases, the use of less reactive vaccines, which can reduce the risk of inflammatory conditions and thus of fibrosarcomas, can also be considered. An open dialogue with the veterinarian about the latest developments and recommendations in vaccine technology can help make the best decision for your cat’s health.
Outlook on current research
In the future, tumor tissue will be genetically examined more frequently. This involves specifically searching for genetic material of the virus that integrates into the genetic structure (DNA) of the infected host cell and remains there. This integrated viral DNA can alter the body’s own cells, causing them to degenerate into cancer cells. This would allow for a more reliable determination of whether a fibrosarcoma is truly virus-induced and how aggressively it is likely to behave.
Many feline sarcomas develop without a virus (e.g., vaccine-associated feline injection site sarcoma, FISS). Comparative studies aim to identify typical patterns so that FeSV cases are not overlooked or confused.
FeSV cannot multiply without the “helper virus” FeLV. Therefore, it is being investigated to what extent consistent testing for the presence of an FeLV infection and vaccination can reduce the risk of FeSV-related Tumors.
FeSV permanently activates cellular, supportive enzymes (tyrosine kinases). In the laboratory, existing kinase inhibitors are being tested to inhibit these signals.
Furthermore, research is being conducted into which cells support the tumor (e.g., certain fibroblasts, macrophages) and why therapies sometimes fail.
“Liquid biopsies” (viral and tumor DNA in the blood) could monitor surgical success and recurrence risk in the future – in addition to imaging and clinical examination.
Frequently asked questions (FAQs)
How does it differ from vaccine-associated sarcoma (FISS)?
FISS is usually solitary and develops at injection sites; FeSV Tumors are more often multifocal, grow rapidly, and are found in FeLV-positive cats. The causes are different and require different diagnostic considerations.
How does a cat get infected?
FeSV requires FeLV as a “helper”. FeLV is primarily transmitted through saliva (close social contact, mutual grooming, bite wounds). Humans are not at risk.
What are the typical symptoms?
Rapidly growing, firm nodules in the skin/subcutaneous tissue, sometimes several at once; possibly Weight loss, lethargy. Pain may be absent, even though the tumor grows aggressively.
Which cats are particularly at risk?
FeLV-positive animals and populations with unclear FeLV status. Outdoor cats and multi-cat households without a testing/vaccination strategy carry a higher risk.
How is the diagnosis made?
Fine-needle aspirate or biopsy with histopathology. Additionally, FeLV/FeSV detection (antigen test, PCR in blood/tumor) and staging (imaging, lymph nodes) to assess the extent and chances of therapy.
What treatment options are available?
Primary radical surgical removal with wide safety margins; supplemented by radiation therapy depending on the location. Chemotherapy or targeted drugs have limited evidence to date and are weighed on a case-by-case basis.
What is the prognosis?
Guarded: high local recurrence rate and possible metastasis. FeLV co-infection worsens the overall prognosis; early, consistent surgery improves the chances.
Can it be prevented?
Yes: FeLV testing and vaccination, keep new arrivals under quarantine initially, monitor contacts, regular health checks. Indirectly, FeLV control also reduces the FeSV risk.
What does this mean for daily life with an affected cat?
Other cats in the household should be FeLV-tested and vaccinated if necessary; avoid close contact with FeLV-negative animals. Monitor nodules, wound healing, and general condition; early feedback to the veterinarian allows for timely follow-up treatment.
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.